SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-016156
Filing Date
2021-11-17
Accepted
2021-11-17 17:15:47
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20210930x10q.htm   iXBRL 10-Q 2745371
2 EX-31.1 cgtx-20210930xex31d1.htm EX-31.1 16150
3 EX-31.2 cgtx-20210930xex31d2.htm EX-31.2 16847
4 EX-32.1 cgtx-20210930xex32d1.htm EX-32.1 9976
5 EX-32.2 cgtx-20210930xex32d2.htm EX-32.2 10084
  Complete submission text file 0001558370-21-016156.txt   8720126

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20210930.xsd EX-101.SCH 51815
7 EX-101.CAL cgtx-20210930_cal.xml EX-101.CAL 48510
8 EX-101.DEF cgtx-20210930_def.xml EX-101.DEF 194854
9 EX-101.LAB cgtx-20210930_lab.xml EX-101.LAB 463884
10 EX-101.PRE cgtx-20210930_pre.xml EX-101.PRE 365496
11 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20210930x10q_htm.xml XML 1433434
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 211421502
SIC: 2836 Biological Products, (No Diagnostic Substances)